Delivery Order 75N93018D00008-75N93022F00001
Award Date
1/3/22
Potential Completion Date
9/30/24
Potential Value
$554K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Curia Global Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Albany, NY 12212, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases (HHS-NIH-NIAID) awarded a $1,056,500 delivery order to Curia Global Inc., doing business as Amri, under the prime contractor's Nonclinical Services for Development of Interventional Agents indefinite-delivery/indefinite-quantity master contract. The delivery order is for the manufacture of MBX-400, with work to be performed by Amri in Albany, New York between...
This federal contract award, valued at $1,905,868.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to Curia Global Inc. (doing business as Amri), a leading global contract development and manufacturing organization (CDMO). The contract is for nonclinical services to support the development of interventional agents for infectious diseases. This is a delivery order contract under the Nonclinical Services for Development of Interventional Agents...
Curia Global Inc., doing business as Amri, has been awarded a $620,125 delivery order against the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases' Nonclinical Services for Development of Interventional Agents indefinite-delivery/indefinite-quantity contract. The delivery order is for scale-up synthesis of APX2039, a novel GWT1 enzyme inhibitor in fungi, in support of NIH's efforts to develop new treatments for...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases (HHS-NIH-NIAID) awarded a $443,000 delivery order against the Nonclinical Services for Development of Interventional Agents indefinite-delivery/indefinite-quantity (IDIQ) multiple award contract to Curia Global Inc., doing business as Amri. This firm fixed price order is for non-clinical services and will be performed in Spain from September 14, 2022 through December...
This is a $3,453,835.19 delivery order awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke (NINDS) to Curia Global Inc., doing business as Amri, a for-profit manufacturer. The contract is for the Medicinal Chemistry Support Program for Therapeutic Development, which provides chemistry, manufacturing, and controls development; exploratory chemistry; hit-to-lead chemistry;...
This contract was awarded by the National Institute of Allergy and Infectious Diseases, part of the Department of Health and Human Services' National Institutes of Health, to Curia Global Inc. (doing business as Amri) to complete the synthesis of 400 grams of non-Good Manufacturing Practice (non-GMP) antibiotic candidate FG-960-2. The $186,237.00 contract has a cost-plus-fixed-fee pricing type and a completion date of January 30, 2021. It was issued as a delivery order under the National...
This federal contract award is for Task C03 under the Nonclinical Services for Development of Interventional Agents contract, a delivery order awarded to Curia Global Inc., doing business as Amri. Amri is a leading contract development and manufacturing organization (CDMO) that provides a wide range of pharmaceutical research and development services to federal agencies, particularly the National Institutes of Health (NIH) and its institutes. The award has a total ceiling value of $860,162.70...
This is a federal contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke to Curia Global Inc., doing business as Amri, a leading global contract development and manufacturing organization (CDMO). The $2,873,042.91 contract is for the Medicinal Chemistry Support Program for Therapeutic Development, under which Curia will provide a range of chemistry, manufacturing, and controls development...
The Department of Health and Human Services National Institutes of Health National Institute of Neurological Disorders and Stroke awarded a $3,173,498.83 cost-plus-fixed-fee Delivery Order contract to Curia Global Inc., doing business as Amri, for Exploratory Chemistry services under the Medicinal Chemistry Support Program for Therapeutic Development. The contract has a completion date of February 1, 2026 and does not have a small business set-aside designation. Curia, a global contract...
This is a delivery order contract awarded by the National Institute of Mental Health (NIMH) to Curia Global Inc., doing business as Amri, a leading contract development and manufacturing organization (CDMO). The contract is part of the Medicinal Chemistry Support Program for Therapeutic Development (MCSP) and is for exploratory chemistry research related to Alzheimer's disease. The contract has a ceiling value of $607,397.30 and a performance period ending on June 2, 2025. The contract is a...